Roberta S Allen

Author PubWeight™ 6.18^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	The beta3 nicotinic receptor subunit: a component of alpha-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors.	J Neurosci	2003	1.73
2	Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trial.	Blood	2002	1.20
3	Voreloxin, a first-in-class anticancer quinolone derivative, in relapsed/refractory solid tumors: a report on two dosing schedules.	Clin Cancer Res	2010	0.91
4	Radioimmunotherapy of non-Hodgkin's lymphoma: clinical development of the Zevalin regimen.	Biotechnol Annu Rev	2004	0.85
5	Initial trials of anti-CD80 monoclonal antibody (Galiximab) therapy for patients with relapsed or refractory follicular lymphoma.	Clin Lymphoma	2003	0.79
6	Clinical and histologic response to single-dose treatment of moderate to severe psoriasis with an anti-CD80 monoclonal antibody.	J Am Acad Dermatol	2002	0.78